SANES

9.205

+0.22%↑

BBVA

18.51

-0.24%↓

ALV

369.9

-0.03%↓

MUV2

540.6

-0.18%↓

INGA

22.295

-0.16%↓

SANES

9.205

+0.22%↑

BBVA

18.51

-0.24%↓

ALV

369.9

-0.03%↓

MUV2

540.6

-0.18%↓

INGA

22.295

-0.16%↓

SANES

9.205

+0.22%↑

BBVA

18.51

-0.24%↓

ALV

369.9

-0.03%↓

MUV2

540.6

-0.18%↓

INGA

22.295

-0.16%↓

SANES

9.205

+0.22%↑

BBVA

18.51

-0.24%↓

ALV

369.9

-0.03%↓

MUV2

540.6

-0.18%↓

INGA

22.295

-0.16%↓

SANES

9.205

+0.22%↑

BBVA

18.51

-0.24%↓

ALV

369.9

-0.03%↓

MUV2

540.6

-0.18%↓

INGA

22.295

-0.16%↓

Search

Gimv NV

Atvērts

SektorsFinanšu

44.9 0.45

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

44.6

Max

45

Galvenie mērījumi

By Trading Economics

Pārdošana

114M

P/E

Sektora vidējais

6.165

29.357

EPS

2.43

Darbinieki

94

EBITDA

76M

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

1.7B

Iepriekšējā atvēršanas cena

44.45

Iepriekšējā slēgšanas cena

44.9

Ziņu noskaņojums

By Acuity

50%

50%

203 / 528 Rangs Finance

Gimv NV Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 27. nov. 16:49 UTC

Iegādes, apvienošanās, pārņemšana

Deutsche Boerse in Talks to Buy Fund-Tech Platform Allfunds in $6 Billion Deal

2025. g. 27. nov. 15:32 UTC

Iegādes, apvienošanās, pārņemšana

TotalEnergies, Repsol in Talks to Combine U.K. North Sea Assets, Cinco Dias Says, Citing Sources

2025. g. 27. nov. 23:50 UTC

Tirgus saruna

Nikkei May Trade Rangebound Amid Caution Over Economic Outlook -- Market Talk

2025. g. 27. nov. 23:50 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 27. nov. 16:05 UTC

Tirgus saruna

Canadian Job Vacancies Rise for Fist Time Since Start of 2024 -- Market Talk

2025. g. 27. nov. 16:04 UTC

Tirgus saruna

Canadian Payroll Employment Pulls Back in September, Offsetting Recent Gains -- Market Talk

2025. g. 27. nov. 15:54 UTC

Iegādes, apvienošanās, pārņemšana

Allfunds Shares Rise 21% After Deutsche Boerse Says Started Acquisition Talks

2025. g. 27. nov. 15:44 UTC

Iegādes, apvienošanās, pārņemšana

Deutsche Boerse: No Certainty Talks Will Result in Transaction

2025. g. 27. nov. 15:43 UTC

Iegādes, apvienošanās, pārņemšana

Deutsche Boerse: Allfunds Board of Directors Has Agreed to Enter Exclusive Talks

2025. g. 27. nov. 15:42 UTC

Iegādes, apvienošanās, pārņemšana

Deutsche Boerse: Nonbinding Proposal is To Acquire Allfunds at EUR8.80 a Share

2025. g. 27. nov. 15:41 UTC

Iegādes, apvienošanās, pārņemšana

Deutsche Boerse in Talks With Allfunds on Possible Acquisition

2025. g. 27. nov. 15:11 UTC

Tirgus saruna

Dollar Could Fall in 2026 as U.S. Rate Cuts Bite -- Market Talk

2025. g. 27. nov. 14:26 UTC

Tirgus saruna

Hermes' Outperformance Gap Could Narrow -- Market Talk

2025. g. 27. nov. 14:11 UTC

Tirgus saruna

Lack of Major Budget Surprises Don't Justify Continued Sterling Strength -- Market Talk

2025. g. 27. nov. 14:11 UTC

Tirgus saruna

Market Talk Roundup: Latest on U.S. Politics

2025. g. 27. nov. 13:35 UTC

Tirgus saruna

Richemont Looks Set to Continue Outgrowing Peers -- Market Talk

2025. g. 27. nov. 13:33 UTC

Tirgus saruna

Sterling's Post-Budget Gains Are Probably Over -- Market Talk

2025. g. 27. nov. 13:22 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 27. nov. 13:22 UTC

Tirgus saruna

Kering's Plan to Revive Gucci Needs More Clarity -- Market Talk

2025. g. 27. nov. 13:17 UTC

Tirgus saruna

LVMH Should Be Able to Recover Next Year -- Market Talk

2025. g. 27. nov. 11:13 UTC

Tirgus saruna

European Gas Prices Come Under Pressure -- Market Talk

2025. g. 27. nov. 11:07 UTC

Peļņas

Genting: Positive About Prospects Over Longer Term

2025. g. 27. nov. 11:06 UTC

Peļņas

Genting: Cautious on Near-Term Prospects of Leisure, Hospitality Industry

2025. g. 27. nov. 11:04 UTC

Peļņas

Genting: International Travel Demand Expected to Remain Resilient

2025. g. 27. nov. 11:04 UTC

Peļņas

Genting: Global Growth Expected to Remain Subdued

2025. g. 27. nov. 11:04 UTC

Peļņas

Genting: Ebitda Partly Weighed by Stronger Ringgit Vs. Singapore Dollar, British Pound, U.S. Dollar

2025. g. 27. nov. 10:59 UTC

Peļņas

Genting Bhd 3Q Net Profit Fell 86% on Year

2025. g. 27. nov. 10:58 UTC

Peļņas

Genting Bhd 3Q Rev Rose 14% on Year

2025. g. 27. nov. 10:56 UTC

Peļņas

Genting Bhd 3Q Net MYR30.3M

2025. g. 27. nov. 10:56 UTC

Peļņas

Genting Bhd 3Q EPS MYR0.0079

Salīdzinājums

Cenas izmaiņa

Gimv NV Prognoze

Vērtējuma vienprātība

By TipRanks

0 ratings

0

Pirkt

0

Turēt

0

Pārdot

Noskaņojums

By Acuity

203 / 528 Rangs Finanšu

Ziņu noskaņojums

Neutral

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Gimv NV

Gimv NV is a private equity and venture capital firm specializing in direct and fund of funds investments. For direct investments, the firm specializes in buyouts, growth capital, middle market, debt, shareholder loans, seed, startups, early to mid-stage, late venture, public to private transactions, small and medium sized enterprises, later stage, mature, replacement capital, bridge financing, and recapitalization. Within fund of funds, it seeks to invest in venture capital and private equity funds. It seeks to invest in high performance growth companies that respond to that can speed up their internal growth through acquisitions. The firm typically invests in consumer, connected consumer, fintech; health and care; smart industries; and sustainable cities. Within consumer, it seeks to provide growth capital to emerging leaders. Within health and care platform, the firm seeks to invest in companies that can grow either organically or through a buy and build strategy. Within consumer, it focuses on consumer goods, food and beverage, healthy food, sport, convenience food, personal luxury, career, home & deco, baby & kids, pet products, retail, consumer services, media and content, travel and leisure, education, digital economy and online sectors. Within health and care sector, it focuses on life sciences, medtech, and health and care services. The firm focuses on biotech/biopharma comprising drugs, platform technologies, vaccines and diagnostic tests, preclinical, early clinical, and late clinical, medtech such as medical devices, consumables, IT and small equipment, and health and care services-based companies. It also seeks to be an active shareholder, preferably lead or co-lead in its investments. Within smart industries, it focuses on equipment, services and tools for resource efficient development and production, automotive and aerospace, both optimizing of the existing and development of new means of transport, software and services harnessing the flexibility of the cloud, smart data management and advanced c
help-icon Live chat